Do acetylcholinesterase inhibitors boost synaptic scaling in Alzheimer's disease?
- 1 May 2004
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 27 (5), 245-249
- https://doi.org/10.1016/j.tins.2004.03.006
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- The Cholinergic Hypothesis of Age and Alzheimer's Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug DevelopmentJournal of Pharmacology and Experimental Therapeutics, 2003
- Cholinesterases: New Roles in Brain Function and in Alzheimer's DiseaseNeurochemical Research, 2003
- Alzheimer's disease and Aβ toxicity: from top to bottomNature Reviews Neuroscience, 2001
- Cell Death or Synaptic Loss in Alzheimer DiseaseJournal of Neuropathology and Experimental Neurology, 2000
- Alzheimer's Disease and the Amyloid β ProteinJournal of Neurochemistry, 1999
- Clinical Assessment of Memory Disorders in Amnesia and DementiaAnnual Review of Psychology, 1995
- Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25–35NeuroReport, 1993
- Neurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's DiseaseScience, 1989
- Neurons with graded response have collective computational properties like those of two-state neurons.Proceedings of the National Academy of Sciences, 1984
- Neural networks and physical systems with emergent collective computational abilities.Proceedings of the National Academy of Sciences, 1982